Drug-induced osteonecrosis of the jaw: the state of the art
Osteonecrosis of the jaw (ONJ) is a rare adverse event of antiresorptive drugs such as bisphosphonates (BP) and denosumab (DMAb). The diagnosis of ONJ is considered in cases where exposed bone in the maxillofacial region does not heal within 8 weeks in a patient previously treated with an antiresorp...
Saved in:
Main Authors: | A. Fassio (Author), F. Bertoldo (Author), L. Idolazzi (Author), O. Viapiana (Author), M. Rossini (Author), D. Gatti (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Insight into the WNT system and its drug related response
by: S. Tamanini, et al.
Published: (2013) -
A case of mandible Paget's disease of the bone treated with intravenous neridronate
by: A. Fassio, et al.
Published: (2016) -
Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013) -
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis
by: A. Fassio, et al.
Published: (2016) -
Clinical development of neridronate: potential for new applications
by: Gatti D, et al.
Published: (2013)